Cargando…

Outcomes of deceased donor liver transplantation from elderly donors

BACKGROUND: Favorable outcomes achieved after deceased donor liver transplantation (DDLT) suggest that use of elderly donors may be an effective way to expand donor pool. METHODS: This was a retrospective analysis of adult DDLT using elderly donors. It was a double-arm study that compared posttransp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Minjae, Hwang, Shin, Ahn, Chul-Soo, Kim, Ki-Hun, Moon, Deok-Bog, Ha, Tae-Yong, Song, Gi-Won, Jung, Dong-Hwan, Park, Gil-Chun, Yoon, Young-In, Kang, Woo-Hyoung, Cho, Hwui-Dong, Na, Byeong-Gon, Kim, Sang Hoon, Lee, Sung-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235342/
https://www.ncbi.nlm.nih.gov/pubmed/35769522
http://dx.doi.org/10.4285/kjt.20.0051
Descripción
Sumario:BACKGROUND: Favorable outcomes achieved after deceased donor liver transplantation (DDLT) suggest that use of elderly donors may be an effective way to expand donor pool. METHODS: This was a retrospective analysis of adult DDLT using elderly donors. It was a double-arm study that compared posttransplant outcomes to ascertain whether use of elderly donors (aged ≥76 years) has adverse effects on outcome of DDLT. Elderly donor study group included 14 donors aged ≥76 years and elderly donor control group comprised 39 donors aged 66–75 years. RESULTS: Mean donor age of the study and control groups was 78.2±3.1 years and 68.9±2.7 years, respectively (P<0.001). Other clinical parameters were comparable between these two donor groups. The 1-, 3-, and 5-year graft survival rates in the elderly study group were 83.6%, 59.7%, and 59.7%, respectively, and those in the elderly control group were 79.4%, 68.1%, and 59.6%, respectively (P=0.97). The overall 1-, 3-, and 5-year survival rates after donation from elderly study group were 83.6%, 59.7%, and 59.7%, respectively, and those after donation from control group were 79.3%, 72.1%, and 64.1%, respectively (P=0.74). Regarding overall patient survival, univariate analysis identified pretransplant requirement for ventilator support (P=0.021) and pretransplant renal replacement therapy (P=0.025) as statistically significant risk factors; however, neither was significant on multivariate analysis. CONCLUSIONS: The results of this study suggest that using an elderly donor graft might not worsen the posttransplant outcomes significantly; thus, advanced age per se may not be an exclusion criterion for organ donation.